Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 8.443\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Brc1cccc(OCCCNC2CCCC2)c1.O=C(O)C(=O)O
b.) O=C(NCCCN1CCOCC1)C(=O)NCC1OCCN1S(=O)(=O)c1ccc(Br)cc1
Answer: b. O=C(NCCCN1CCOCC1)C(=O)NCC1OCCN1S(=O)(=O)c1ccc(Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCCCN1CCOCC1)C(=O)NCC1OCCN1S(=O)(=O)c1ccc(Br)cc1
O=C(NCCCN1CCOCC1)C(=O)NCC1OCCN1S(=O)(=O)c1ccc(Br)cc1
N'-[[4-(4-bromophenyl)sulfonyl-1,4-oxazolidin-5-yl]methyl]-N-(3-morpholin-4-ylpropyl)oxamide